# Indications and Usage Section of Labeling for Human Prescription Drug and Biological Products — Content and Format Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/indications-and-usage-section-of-labeling-for-human-prescription-drug-and-biological-products-content-and-format-guidance-for-industry/7d286113-df13-47f4-bc30-1a4d819e56c9

> FDA guidance document: Indications and Usage Section of Labeling for Human Prescription Drug and Biological Products — Content and Format Guidance for Industry. Issue date: July 06, 2018. Get complete insights and analysis.

---

## Details

- Title: Indications and Usage Section of Labeling for Human Prescription Drug and Biological Products — Content and Format Guidance for Industry
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2018-07-06
- Comment Close Date: 2018-10-05
- Last Changed: 2019-10-18
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2018-D-1895">FDA-2018-D-1895</a>

## Related Documents

- [Labeling for Biosimilar and Interchangeable Biosimilar Products](https://www.globalkeysolutions.net/guidances/guidance-document/labeling-for-biosimilar-and-interchangeable-biosimilar-products/54a5f712-03f5-4993-b0d7-6a1c2f261eff)
- [Drug Abuse and Dependence Section of Labeling for Human Prescription Drug and Biological Products —  Content and Format   Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/drug-abuse-and-dependence-section-of-labeling-for-human-prescription-drug-and-biological-products-content-and-format-guidance-for-industry/e65bdb77-e74c-42d7-aab4-482af24834d1)
- [Dosage and Administration Section of Labeling for Human Prescription Drug and Biological Products — Content and Format](https://www.globalkeysolutions.net/guidances/guidance-document/dosage-and-administration-section-of-labeling-for-human-prescription-drug-and-biological-products-content-and-format/e2343785-81a2-4852-aba8-7ffd3a086deb)